Department of Bio-Convergence System, Hoseo University, Asan, South Korea.
College of Biological & Environmental Sciences, Zhejiang Wanli University, Ningbo, China.
J Med Food. 2022 Apr;25(4):355-366. doi: 10.1089/jmf.2021.K.0144.
We investigated the molecular mechanism by which (HCT) may intervene in coronavirus disease 2019 (COVID-19) and COVID-19-induced cytokine storms using network pharmacology and molecular docking approaches. Using the Traditional Chinese medicine Systems Pharmacology Database and Analysis Platform (TCMSP), a "component-target-pathway" topology map of HCT for COVID-19 treatment was constructed using Cytoscape. Core target genes were analyzed using the STRING database, and the signal pathway map and biological mechanism of COVID-19 therapy were obtained using cluster profilers. Active components of HCT were docked with severe respiratory syndrome coronavirus 2 (SARS-CoV-2) 3C-like protease (3CL) and RNA-dependent RNA polymerase (RdRp) using AutoDockTools. Data visualization and statistical analysis were conducted using the R program. A molecular dynamic simulation was carried out with the Groningen Machine for Chemical Simulation program. HCT had six active anti-COVID-19 ingredients and 45 molecular targets. Their crucial target proteins for COVID-19 treatment were the (nuclear factor kappa B [NF-B] p65 subunit), interleukin 6, and mitogen-activated protein kinase 1. In functional enrichment analysis, the potential molecular targets of active components of HCT for COVID-19 treatment belonged to 18 signaling pathways (adjusted = 2.12E-11). Gene ontology obtained by Kyoto Encyclopedia of Genes and Genome enrichment screening showed that the primary mechanism of COVID-19 treatment was upregulation of protein kinase C followed by downregulations of T cell differentiation and proliferation and NF-B signaling. Molecular docking showed that the active components of HCT (quercetin and kaempferol) had similar binding affinities for 3CL and RdRp, primary COVID-19 target proteins as did clinically used drugs. These results were confirmed with molecular dynamics simulation. In conclusion, multiple components of HCT, especially quercetin and kaempferol, have the potential to treat COVID-19 infection and COVID-19-induced cytokine storm by targeting multiple proteins.
我们采用网络药理学和分子对接方法研究了 (HCT) 可能干预 2019 年冠状病毒病 (COVID-19) 和 COVID-19 诱导的细胞因子风暴的分子机制。使用中药系统药理学数据库和分析平台 (TCMSP),我们使用 Cytoscape 构建了 HCT 治疗 COVID-19 的“成分-靶标-途径”拓扑图。使用 STRING 数据库分析核心靶基因,并使用聚类分析程序获得 COVID-19 治疗的信号通路图和生物学机制。使用 AutoDockTools 将 HCT 的活性成分与严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 3C 样蛋白酶 (3CL) 和 RNA 依赖性 RNA 聚合酶 (RdRp) 对接。使用 R 程序进行数据可视化和统计分析。使用 Groningen 化学模拟程序进行分子动力学模拟。HCT 有六种活性抗 COVID-19 成分和 45 个分子靶点。它们治疗 COVID-19 的关键靶蛋白是核因子 kappa B (NF-B) p65 亚基、白细胞介素 6 和丝裂原活化蛋白激酶 1。在功能富集分析中,HCT 活性成分治疗 COVID-19 的潜在分子靶点属于 18 个信号通路 (调整 = 2.12E-11)。京都基因与基因组百科全书富集筛选获得的基因本体显示,COVID-19 治疗的主要机制是上调蛋白激酶 C,随后下调 T 细胞分化和增殖以及 NF-B 信号。分子对接表明,HCT 的活性成分 (槲皮素和山奈酚) 对 3CL 和 RdRp 的结合亲和力与临床使用的药物相似,也是 COVID-19 的主要靶蛋白。这些结果通过分子动力学模拟得到了证实。总之,HCT 的多种成分,特别是槲皮素和山奈酚,通过靶向多种蛋白质,有可能治疗 COVID-19 感染和 COVID-19 诱导的细胞因子风暴。